0001192482-19-000193.txt : 20190415 0001192482-19-000193.hdr.sgml : 20190415 20190415152549 ACCESSION NUMBER: 0001192482-19-000193 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190415 DATE AS OF CHANGE: 20190415 EFFECTIVENESS DATE: 20190415 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aro Biotherapeutics Co CENTRAL INDEX KEY: 0001773305 IRS NUMBER: 823212502 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-337325 FILM NUMBER: 19748464 BUSINESS ADDRESS: STREET 1: 3675 MARKET STREET, SUITE 200 CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 215-544-1175 MAIL ADDRESS: STREET 1: 3675 MARKET STREET, SUITE 200 CITY: PHILADELPHIA STATE: PA ZIP: 19104 D 1 primary_doc.xml X0708 D LIVE 0001773305 Aro Biotherapeutics Co 3675 MARKET STREET, SUITE 200 PHILADELPHIA PA PENNSYLVANIA 19104 215-544-1175 DELAWARE None None Corporation true 2017 Susan B Dillon c/o Aro Biotherapeutics Company 3675 Market Street, Suite 200 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Director Karyn O'Neil c/o Aro Biotherapeutics Company 3675 Market Street, Suite 200 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Director Mark V. Laurenzi c/o Aro Biotherapeutics Company 3675 Market Street, Suite 200 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Elizabeth Anderson c/o Aro Biotherapeutics Company 3675 Market Street, Suite 200 Philadelphia PA PENNSYLVANIA 19104 Director Bruce Peacock c/o Aro Biotherapeutics Company 3675 Market Street, Suite 200 Philadelphia PA PENNSYLVANIA 19104 Director Biotechnology Decline to Disclose 06b false 2019-03-29 false true true false 0 4900000 3500000 1400000 false 3 0 0 0 false Aro Biotherapeutics Co /s/ Mark V. Laurenzi Mark V. Laurenzi Chief Administrative Officer 2019-04-15